Histopathologic risk factors in retinoblastoma: a retrospective study of 172 patients treated in a single institution.
about
RetinoblastomaDysmorphic phenotype and neurological impairment in 22 retinoblastoma patients with constitutional cytogenetic 13q deletionGuidelines for imaging retinoblastoma: imaging principles and MRI standardization.Impact of tumor-associated macrophages in LH(BETA)T(AG) mice on retinal tumor progression: relation to macrophage subtype.Gelatinase expression in retinoblastoma: modulation of LH(BETA)T(AG) retinal tumor development by anecortave acetate.Presentation of retinoblastoma at a paediatric eye clinic in ghana.Characteristics of Germline and Non-germline RetinoblastomasA multicentre report from the Mexican Retinoblastoma GroupRetinoblastoma. Fifty years of progress. The LXXI Edward Jackson Memorial Lecture.Histopathologic findings of eyes enucleated after treatment with chemosurgery for retinoblastomaHigh-risk histomorphological features in retinoblastoma and their association with p53 expression: An Indian experienceRetinoblastoma in adults: a case report and literature reviewEstablishment of the relationship between tumor size and range of histological involvement to evaluate the rationality of current retinoblastoma managementNeoadjuvant chemotherapy for extensive unilateral retinoblastoma.Retinoblastoma patients with high risk ocular pathological features: who needs adjuvant therapy?Mouse models of childhood cancer of the nervous systemTumour angiogenesis as a prognostic factor for disease dissemination in retinoblastoma.Predictive factors of invasion in eyes with retinoblastoma enucleated after eye salvage treatments.Blood flow velocity in monocular retinoblastoma assessed by color Doppler.MRI helps depict clinically undetectable risk factors in advanced stage retinoblastomas.Enucleation vs Ophthalmic Artery Chemosurgery for Advanced Intraocular Retinoblastoma: A Retrospective Analysis.Comparison of high-risk histopathological features in eyes with primary or secondary enucleation for retinoblastoma.Orbital retinoblastoma: Present status and future challenges - A review.Retinoblastoma: achieving new standards with methods of chemotherapy.High level amplification of N-MYC is not associated with adverse histology or outcome in primary retinoblastoma tumours.Advanced retinoblastoma treatment: targeting hypoxia by inhibition of the mammalian target of rapamycin (mTOR) in LH(BETA)T(AG) retinal tumors.Innovative ophthalmology.Focal, periocular delivery of 2-deoxy-D-glucose as adjuvant to chemotherapy for treatment of advanced retinoblastomaPresenting signs of retinoblastoma at a tertiary level teaching hospital in Ethiopia.Relationship between histopathological features of chemotherapy treated retinoblastoma and P-glycoprotein expression.
P2860
Q21558539-08BC804D-4A5A-4B7B-B9EF-BFD563D09A7FQ28142341-EC67F469-ACF1-486E-9C06-37F9B5ED31CFQ30471319-9ABD57C1-C200-4714-AF50-FB299C03A008Q33845565-495A6BA0-A41E-4A7D-9790-475724AC81AFQ33938157-2CC4D1E0-AE67-4771-A9B8-61228384968FQ34206492-E77A186E-83F0-47B3-873C-A4DDBCE0DCDBQ34272327-8012730A-2EDA-41EA-9EBC-E9AC6B210248Q34549368-08B07D11-3CE3-417F-BF11-01113455EDFFQ34603733-E1A77882-B271-47F4-8D38-59E7974126E8Q34642217-0FBF465E-284A-4AF6-8A0A-402E3C18A953Q34909575-356282A4-7E88-4730-BBAD-A997863986F7Q35017765-7A534A5F-C5A4-4EB1-94CA-C4F84A3F533BQ35060311-518EE05D-E1A5-4C1B-AAEE-3436AE67F64FQ35590672-85985BF1-3A9C-4E6D-94E7-5EB151E6EF37Q35592280-7BB13144-6064-4277-91F5-5CDB605F6FB8Q35786003-2C786E21-1D69-4E62-96B6-9518832DDCDCQ35895240-0CF0C1EC-3E8F-46CF-BE7F-0FF28C7745F3Q36276642-35EA5BBF-1253-47C6-935E-F3D8456CCEBEQ36364701-8A3EFEB6-EB6E-4610-8DB9-161F90C83068Q36589627-C421B703-7013-44A1-97E5-2A1F0FCFF542Q36853838-EE84A54A-3B17-4782-B593-2159FEC0BEBEQ37490145-2279D0AD-E02A-4F8C-8FA0-80DF69659E07Q38130240-4799DD98-49A0-48D6-AE3C-F94ABFFB8660Q38397827-ADBA2D5E-7FB2-4A3D-92F1-3CC89BD7F4C1Q41787764-BFED68BE-C35A-455A-AA82-34694DD9AFFCQ41824416-4354DC9E-C624-4942-941E-5A2488E91E94Q41828522-EDD01296-4139-41B9-B4A8-CB4947C044E4Q41913294-440D8360-D7A3-439C-8F34-FCF7CC73458AQ46347068-C88B5D3A-A008-4C0F-8FD3-C961227396B0Q46524724-4CEA3710-489C-4B01-A083-EDA07EB52DE5
P2860
Histopathologic risk factors in retinoblastoma: a retrospective study of 172 patients treated in a single institution.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Histopathologic risk factors i ...... eated in a single institution.
@en
type
label
Histopathologic risk factors i ...... eated in a single institution.
@en
prefLabel
Histopathologic risk factors i ...... eated in a single institution.
@en
P2093
P1433
P1476
Histopathologic risk factors i ...... eated in a single institution.
@en
P2093
Asselain B
Desjardins L
Khelfaoui F
Pacquement H
Quintana E
Schlienger P
Validire P
P304
P356
10.1002/(SICI)1097-0142(19960315)77:6<1206::AID-CNCR30>3.3.CO;2-Q
P407
P577
1996-03-01T00:00:00Z